Pharmacological management of bipolar depression: acute treatment, maintenance, and prophylaxis
GLP-1 receptor agonistsincluding semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda)are widely prescribed in the UK for type 2 diabetes and weight management
It is not approved for human or veterinary use, clinical administration, therapeutic applications, or diagnostic procedures of any kind
However, during a severe viral infection or prolonged periods of chronic inflammation, this vital defense system can become overwhelmed and depleted
Experts believe appetite-suppressing drugs may have antidepressant and anti-anxiety effects, potentially due to their anti-inflammatory and anti-oxidative properties
75 GLP-1 and GIP receptors expressed in the hypothalamus and brainstem nuclei regulate appetite, satiety, and energy balance